Next Article in Journal
Previous Article in Journal
Nutrients 2013, 5(9), 3617-3633; doi:10.3390/nu5093617
Article

Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements

 and *
Received: 13 June 2013; in revised form: 16 August 2013 / Accepted: 20 August 2013 / Published: 13 September 2013
View Full-Text   |   Download PDF [240 KB, uploaded 13 September 2013]
Abstract: Saw palmetto supplements are one of the most commonly consumed supplements by men with prostate cancer and/or benign prostatic hyperplasia (BPH). Some studies have found significant improvements in BPH and lower urinary tract symptoms (LUTS) with saw palmetto supplementation, whereas others found no benefits. The variation in the efficacy in these trials may be a result of differences in the putative active components, fatty acids and phytosterols, of the saw palmetto supplements. To this end, we quantified the major fatty acids (laurate, myristate, palmitate, stearate, oleate, linoleate) and phytosterols (campesterol, stigmasterol, β-sitosterol) in 20 commercially available saw palmetto supplements using GC-FID and GC-MS, respectively. Samples were classified into liquids, powders, dried berries, and tinctures. Liquid saw palmetto supplements contained significantly higher (p < 0.05) concentrations of total fatty acids (908.5 mg/g), individual fatty acids, total phytosterols (2.04 mg/g), and individual phytosterols, than the other supplement categories. Powders contained significantly higher (p < 0.05) concentrations of total fatty acids than tinctures, which contain negligible amounts of fatty acids (46.3 mg/g) and phytosterols (0.10 mg/g). Our findings suggest that liquid saw palmetto supplements may be the best choice for individuals who want to take a saw palmetto supplement with the highest concentrations of both fatty acids and phytosterols.
Keywords: saw palmetto; serenoa repens; prostate; benign prostatic hyperplasia; prostate cancer; fatty acids; phytosterols; supplements saw palmetto; serenoa repens; prostate; benign prostatic hyperplasia; prostate cancer; fatty acids; phytosterols; supplements
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Penugonda, K.; Lindshield, B.L. Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements. Nutrients 2013, 5, 3617-3633.

AMA Style

Penugonda K, Lindshield BL. Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements. Nutrients. 2013; 5(9):3617-3633.

Chicago/Turabian Style

Penugonda, Kavitha; Lindshield, Brian L. 2013. "Fatty Acid and Phytosterol Content of Commercial Saw Palmetto Supplements." Nutrients 5, no. 9: 3617-3633.


Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert